Treatment of von Willebrand disease

被引：0

|

作者：

Yoshioka, A ^{[1
]}

机构：

[1] Nara Med Univ, Kashihara, Nara 634, Japan

来源：

HAEMOPHILIA | 2000年 / 6卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：25 / 26

页数：2

相关论文

共 50 条

[31] Toward Personalized Treatment for Patients with Low von Willebrand Factor and Quantitative von Willebrand Disease
O'Donnell, James S.
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2021, 47 (02): : 192 - 200
[32] Treatment of a patient with type 3 von Willebrand disease and alloantibody against von Willebrand factor
Halimeh, S.
Faeser, B.
Budde, U.
Laws, H.
Rott, H.
HAEMOPHILIA, 2010, 16 : 149 - 149
[33] Von Willebrand factor (Vonvendi®): the first recombinant product licensed for the treatment of von Willebrand disease
Franchini, Massimo
Mannucci, Pier Mannuccio
EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (09) : 825 - 830
[34] Von Willebrand factor and von Willebrand disease - Preface
Michiels, JJ
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2001, 14 (02) : VII - VII
[35] Erik von Willebrand - von Willebrand's disease
Shampo, MA
Kyle, RA
MAYO CLINIC PROCEEDINGS, 1996, 71 (11) : 1088 - 1088
[36] Von Willebrand disease
Schneppenheim, R
EUROPEAN JOURNAL OF PEDIATRICS, 1996, 155 (09) : 751 - 752
[37] Von Willebrand disease
Castillo, R
MEDICINA CLINICA, 1998, 111 (16): : 616 - 618
[38] von Willebrand disease
James, Paula D.
Goodeve, Anne C.
GENETICS IN MEDICINE, 2011, 13 (05) : 365 - 376
[39] Von Willebrand disease
Rodeghiero, Francesco
HEMATOLOGY, 2014, 19 (06) : 370 - 371
[40] von Willebrand disease
不详
NATURE REVIEWS DISEASE PRIMERS, 2024, 10 (01):

← 1 2 3 4 5 →